Adalta Ltd has released a press release.
GLP toxicology study commences
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Entitlement Offer Results and Shortfall Notification
- Completion of Capital Raise - $5 million
- AD-214 manufacturing update
- Manufacturing update
- Appendix 4C - Quarter ended 30 September 2018
Later from AdAlta
- Executive team changes
- AdAlta secures licensing deal with GE Healthcare
- Receipt of R&D Tax Incentive
- Tim Oldham Appointed as Chief Executive Officer
- GLP Toxicology study results
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta